A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis: Rare Lung Diseases Consortium
A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis: Rare Lung Diseases Consortium
Sponsor: National Heart, Lung, and Blood Institute NIH DHHS
Enrolling: Male and Female Patients
IRB Number: AAAO5705
Contact: M. Atif Choudhury: 212-342-1518 / mac2463@cumc.columbia.edu
Additional Study Information: In some subtypes, HPS can cause breathing problems and scarring in the lungs (pulmonary fibrosis). One purpose of this research study is to learn more about lung problems in people with HPS. Another purpose of this study is to look at genes (DNA) and how they affect health and disease. Genes are the instruction manual for your body. The genes you get from your parents decide what you look like and how your body behaves. They can also tell us a persons risk for certain diseases and how they will respond to treatment. About 150 people will HPS will be a part of this study. It is hoped that if we can understand how the gene problems in HPS cause lung problems, it will eventually lead to better ways to treat pulmonary fibrosis in HPS.
This study is closed
Investigator
Michaela Anderson, MD
Do You Qualify?
Have you or your child been diagnosed with Hermansky-Pudlak Syndrome (HPS)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
M. Atif Choudhury
mac2463@cumc.columbia.edu
212-342-1518